Financials
Income statement
Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
---|---|---|---|---|
Total reported revenue | 81.1B | 80.7B | 76.0B | 70.7B |
Cost of revenue | 26.0B | 25.8B | 27.3B | 25.5B |
Gross profit | 55.1B | 54.9B | 48.7B | 45.2B |
Operating expense | ||||
Research & development | 14.6B | 12.2B | 12.1B | 12.7B |
Selling general and admin | 5.9B | 5.1B | 5.5B | 5.9B |
Other operating expenses | — | — | — | — |
Operating income | 32.0B | 34.8B | 26.7B | 22.1B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 4.2B | 4.7B | 5.0B | 5.8B |
Other income expense | -329.9M | -373.2M | -3.9B | -1.2B |
Pretax income | 27.5B | 29.7B | 20.4B | 15.2B |
Tax provision | 649.0M | -70.3M | -2.4B | 22.9B |
Net income | 26.9B | 29.8B | 23.4B | -10.1B |
Basic EPS | 0.0 | 0.0 | 0.0 | 0.0 |
Diluted EPS | 0.0 | 0.0 | 0.0 | 0.0 |
Basic average shares | 1.8T | 1.8T | 1.8T | 1.8T |
Diluted average shares | 1.8T | 1.8T | 1.8T | 1.8T |
EBITDA | 43.8B | 47.1B | 41.2B | 36.2B |
Net income from continuing op. | 26.9B | 29.8B | 23.4B | -10.1B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |